Kleinerman, Eugenie S.

Osteosarcoma: The Addition of Muramyl Tripeptide to Chemotherapy Improves Overall Survival—A Report From the Children's Oncology Group

Meyers, P. A., Schwartz, C. L., Krailo, M. D., Healey, J. H., Bernstein, M. L., Betcher, D., Ferguson, W. S., Gebhardt, M. C., Goorin, A. M., Harris, M., et al. (2008) · Journal of Clinical Oncology

Sarcoma Diagnosis and TreatmentBone Tumor Diagnosis and Treatments

Cited by 752

Addition of muramyl tripeptide to chemotherapy for patients with newly diagnosed metastatic osteosarcoma: A report from the Children's Oncology Group

Chou, A. J., Kleinerman, E. S., Krailo, M. D., Chen, Z., Betcher, D. L., Healey, J. H., Conrad, E. U., Nieder, M. L., Weiner, M. A., Wells, R. J., et al. (2009) · Cancer

Sarcoma Diagnosis and TreatmentBone Tumor Diagnosis and Treatments

Cited by 245

Anthracycline-Induced Cardiotoxicity: Causes, Mechanisms, and Prevention

Bhagat, A., & Kleinerman, E. S. (2020) · Advances in Experimental Medicine and Biology

Chemotherapy-induced cardiotoxicity and mitigationCardiac tumors and thrombi

Cited by 208

Toward a Drug Development Path That Targets Metastatic Progression in Osteosarcoma

Khanna, C., Fan, T. M., Gorlick, R., Helman, L. J., Kleinerman, E. S., Adamson, P. C., Houghton, P. J., Tap, W. D., Welch, D. R., Steeg, P. S., et al. (2014) · Clinical Cancer Research

Sarcoma Diagnosis and TreatmentCancer Cells and Metastasis

Cited by 178

A nude mouse model of human osteosarcoma lung metastases for evaluating new therapeutic strategies

Jia, S.-F., Worth, L. L., & Kleinerman, E. S. (1999) · Clinical & Experimental Metastasis

Sarcoma Diagnosis and TreatmentCancer Cells and Metastasis

Cited by 146

Genetically Modified T cells Targeting Interleukin-11 Receptor α-Chain Kill Human Osteosarcoma Cells and Induce the Regression of Established Osteosarcoma Lung Metastases

Huang, G., Yu, L., Cooper, L. J. N., Hollomon, M., Huls, H., & Kleinerman, E. S. (2012) · Cancer Research

CAR-T cell therapy researchImmunotherapy and Immune Responses

Cited by 127

Vaccine efficacy against primary and metastatic cancer with in vitro-generated CD103 + conventional dendritic cells

Zhou, Y., Slone, N., Chrisikos, T. T., Kyrysyuk, O., Babcock, R. L., Medik, Y. B., Li, H. S., Kleinerman, E. S., & Watowich, S. S. (2020) · Journal for ImmunoTherapy of Cancer

Immunotherapy and Immune ResponsesCancer Immunotherapy and Biomarkers

Cited by 112

Murine bone marrow–derived mesenchymal stem cells as vehicles for interleukin‐12 gene delivery into Ewing sarcoma tumors

Duan, X., Guan, H., Cao, Y., & Kleinerman, E. S. (2009) · Cancer

Mesenchymal stem cell researchBacterial Cancer Therapy

Cited by 79

Interleukin-12 Up-Regulates Fas Expression in Human Osteosarcoma and Ewing's Sarcoma Cells by Enhancing Its Promoter Activity

Zhou, Z., Lafleur, E. A., Koshkina, N. V., Worth, L. L., Lester, M. S., & Kleinerman, E. S. (2005) · Molecular Cancer Research

Cytokine Signaling Pathways and InteractionsSarcoma Diagnosis and Treatment

Cited by 31